Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins
Open Access
- 9 December 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (49), 19318-19323
- https://doi.org/10.1073/pnas.0804871105
Abstract
Mitochondrial dysfunction is a prominent feature of Alzheimer disease but the underlying mechanism is unclear. In this study, we investigated the effect of amyloid precursor protein (APP) and amyloid β on mitochondrial dynamics in neurons. Confocal and electron microscopic analysis demonstrated that ≈40% M17 cells overexpressing WT APP (APPwt M17 cells) and more than 80% M17 cells overexpressing APPswe mutant (APPswe M17 cells) displayed alterations in mitochondrial morphology and distribution. Specifically, mitochondria exhibited a fragmented structure and an abnormal distribution accumulating around the perinuclear area. These mitochondrial changes were abolished by treatment with β-site APP-cleaving enzyme inhibitor IV. From a functional perspective, APP overexpression affected mitochondria at multiple levels, including elevating reactive oxygen species levels, decreasing mitochondrial membrane potential, and reducing ATP production, and also caused neuronal dysfunction such as differentiation deficiency upon retinoic acid treatment. At the molecular level, levels of dynamin-like protein 1 and OPA1 were significantly decreased whereas levels of Fis1 were significantly increased in APPwt and APPswe M17 cells. Notably, overexpression of dynamin-like protein 1 in these cells rescued the abnormal mitochondrial distribution and differentiation deficiency, but failed to rescue mitochondrial fragmentation and functional parameters, whereas overexpression of OPA1 rescued mitochondrial fragmentation and functional parameters, but failed to restore normal mitochondrial distribution. Overexpression of APP or Aβ-derived diffusible ligand treatment also led to mitochondrial fragmentation and reduced mitochondrial coverage in neuronal processes in differentiated primary hippocampal neurons. Based on these data, we concluded that APP, through amyloid β production, causes an imbalance of mitochondrial fission/fusion that results in mitochondrial fragmentation and abnormal distribution, which contributes to mitochondrial and neuronal dysfunction.Keywords
This publication has 36 references indexed in Scilit:
- The PINK1/Parkin pathway regulates mitochondrial morphologyProceedings of the National Academy of Sciences of the United States of America, 2008
- Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by ParkinJournal of Neuroscience, 2007
- Mitochondrial Fission and Fusion Mediators, hFis1 and OPA1, Modulate Cellular SenescenceJournal of Biological Chemistry, 2007
- Mitochondrial Morphology and Dynamics in Yeast and Multicellular EukaryotesAnnual Review of Genetics, 2005
- Roles of the Mammalian Mitochondrial Fission and Fusion Mediators Fis1, Drp1, and Opa1 in ApoptosisMolecular Biology of the Cell, 2004
- Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replicationProceedings of the National Academy of Sciences of the United States of America, 2004
- Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's diseaseHuman Molecular Genetics, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian CellsMolecular Biology of the Cell, 2001
- Mitochondrial Diseases in Man and MouseScience, 1999